LGYSF yields 2087.68% · JNJ yields 2.13%● Live data
📍 LGYSF pulled ahead of the other in Year 1
Combined, LGYSF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LGYSF + JNJ for your $10,000?
Ling Yue Services Group Limited operates as a property management company in the People's Republic of China. The company offers a range of property management services, such as security services, cleaning and greening services, and repair and maintenance services to property owners, residents, and property developers, as well as tenants in non-residential properties. It manages a diverse portfolio of properties, including residential properties, commercial properties, and public and other properties. The company also provides value-added services to non-property owners, including preliminary planning and design consultancy, sales office management, pre-delivery, repair and maintenance, property transaction assistance, and security support services; and community value-added services primarily to property owners and residents comprising community space management, decoration and turnkey furnishing, convenient living, and community retail services. As of December 31, 2021, it had been contracted to manage 183 properties with an aggregate contracted GFA of approximately 20.8 million square meters under its management. The company was founded in 2002 and is headquartered in Chengdu, the People's Republic of China.
Full LGYSF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.